• Accueil >
  • Publications >
  • Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study

1 août 2019Annals of Oncology

DOI : 10.1093/annonc/mdz176

Auteurs

L. Khoja, E.G. Atenafu, S. Suciu, S. Leyvraz, T. Sato, E. Marshall, U. Keilholz, L. Zimmer, S.P. Patel, S. Piperno-Neumann, J. Piulats, T.T. Kivelä, C. Pfoehler, S. Bhatia, P. Huppert, L.B.J. Van Iersel, I.J.M. De Vries, N. Penel, T. Vogl, T. Cheng, G. Fiorentini, F. Mouriaux, A. Tarhini, P.M. Patel, R. Carvajal, A.M. Joshua